Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
BJOG ; 122(7): 994-1000, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25039582

ABSTRACT

OBJECTIVE: To compare the growth and development of children born to mothers with gestational diabetes mellitus (GDM) requiring pharmacological treatment, and randomised to treatment with metformin or insulin. DESIGN: Follow-up of a randomised controlled trial (RCT) comparing metformin and insulin treatment of GDM. SETTING: Data were gathered during routine visits to child welfare clinics at the ages of 6, 12, and 18 months, including weight and height measurements, and assessment of motor, social, and linguistic development. SAMPLE: The children of mothers with GDM randomised to metformin (n = 47) or insulin (n = 50) treatment during pregnancy. METHODS: Data were collected from the structured questionnaire filled in at the child welfare clinics. MAIN OUTCOME MEASURES: The growth and development of the children until the age of 18 months. RESULTS: Children exposed to metformin were significantly heavier (10.47 versus 9.85 kg, 95% CI 0.04-1.20) at the age of 12 months and taller and heavier (83.9 vs 82.2 cm, 95% CI 0.23-3.03, 12.05 vs 11.32 kg, 95% CI 0.04-1.43) at the age of 18 months. The mean ponderal index (PI) did not differ significantly. The motor, social, or linguistic development evaluated at the age of 18 months did not differ between the groups. CONCLUSIONS: Children prenatally exposed to metformin were heavier at the 12 months measurements and taller and heavier at the 18 months measurements than those exposed to insulin, but their body composition defined by PI did not differ. Over the short term, metformin does not seem to be harmful with regards to early motor, linguistic, or social development.


Subject(s)
Body Height/physiology , Body Weight/physiology , Child Development/physiology , Diabetes, Gestational/drug therapy , Hypoglycemic Agents/therapeutic use , Adult , Female , Follow-Up Studies , Humans , Infant , Insulin/therapeutic use , Male , Metformin/therapeutic use , Pregnancy , Randomized Controlled Trials as Topic , Surveys and Questionnaires
2.
Eur J Endocrinol ; 169(5): 605-11, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23959786

ABSTRACT

OBJECTIVE: Gestational diabetes mellitus (GDM) is associated with an increased risk of subsequent diabetes and metabolic syndrome (MS). The independent significance of overweight, often associated with GDM, is controversial. This study was aimed to investigate the prevalence of MS and carotid intima-media thickness (CIMT) values in normal and overweight women with previous insulin-treated GDM and control without GDM 19 years after the index pregnancy. METHODS: The study group consisted of 61 women with prior GDM and 55 controls who gave birth in Oulu University Hospital between 1988 and 1993. These women were further divided into subgroups according to pre-pregnancy BMI (<25 or ≥25 kg/m(2)). In 2008-2010, anthropometrics and blood pressure were measured, blood samples were taken, and an oral glucose tolerance test was performed to investigate the components of MS. CIMT was measured by Doppler ultrasound. RESULTS: Total prevalence of MS was 62% in the GDM group and 31% in the control group (P=0.001); it was highest (86%) in GDM women with pre-pregnancy overweight. CIMT was significantly thicker (0.67 vs 0.56 mm, P=0.007) and more often abnormal (71.7 vs 45.3%, P=0.004) in the GDM group compared with the controls. In logistic regression analysis, the strongest factor predicting MS in the whole study population was pre-pregnancy overweight. CONCLUSIONS: Pre-pregnancy overweight was the strongest predictive factor for later MS, whereas GDM indicated increased risk of subsequent diabetes and subclinical atherosclerosis. The risk of MS was highest when both of these factors were present.


Subject(s)
Diabetes Complications/epidemiology , Diabetes, Gestational/epidemiology , Metabolic Syndrome/epidemiology , Metabolic Syndrome/etiology , Overweight/complications , Overweight/epidemiology , Adult , Anthropometry , Atherosclerosis/complications , Atherosclerosis/epidemiology , Blood Glucose/metabolism , Blood Pressure/physiology , Carotid Intima-Media Thickness , Diabetes Mellitus, Type 2/epidemiology , Dyslipidemias/epidemiology , Female , Finland/epidemiology , Follow-Up Studies , Glucose Tolerance Test , Humans , Insulin/blood , Logistic Models , Middle Aged , Parity , Pregnancy , Risk Factors
3.
Biochim Biophys Acta ; 1828(3): 932-7, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23220446

ABSTRACT

Lipid self-organization is believed to be essential for shaping the lateral structure of membranes, but it is becoming increasingly clear that also membrane proteins can be involved in the maintenance of membrane architecture. Cholesterol is thought to be important for the lateral organization of eukaryotic cell membranes and has also been implicated to take part in the sorting of cellular transmembrane proteins. Hence, a good starting point for studying the influence of lipid-protein interactions on membrane trafficking is to find out how transmembrane proteins influence the lateral sorting of cholesterol in phospholipid bilayers. By measuring equilibrium partitioning of the fluorescent cholesterol analog cholestatrienol between large unilamellar vesicles and methyl-ß-cyclodextrin the effect of hydrophobic matching on the affinity of sterols for phospholipid bilayers was determined. Sterol partitioning was measured in 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) bilayers with and without WALP19, WALP23 or WALP27 peptides. The results showed that the affinity of the sterol for the bilayers was affected by hydrophobic matching. An increasing positive hydrophobic mismatch led to stronger sterol binding to the bilayers (except in extreme situations), and a large negative hydrophobic mismatch decreased the affinity of the sterol for the bilayer. In addition, peptide insertion into the phospholipid bilayers was observed to depend on hydrophobic matching. In conclusion, the results showed that hydrophobic matching can affect lipid-protein interactions in a way that may facilitate the formation of lateral domains in cell membranes. This could be of importance in membrane trafficking.


Subject(s)
Lipid Bilayers/chemistry , Peptides/chemistry , Phospholipids/chemistry , Sterols/chemistry , 1,2-Dipalmitoylphosphatidylcholine/chemistry , Biophysics/methods , Cholestenes/chemistry , Dimyristoylphosphatidylcholine/chemistry , Dose-Response Relationship, Drug , Hydrophobic and Hydrophilic Interactions , Kinetics , Lipids/chemistry , Models, Chemical , Models, Statistical , Phosphatidylcholines/chemistry , beta-Cyclodextrins/chemistry
4.
BJOG ; 118(7): 880-5, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21083860

ABSTRACT

OBJECTIVE: To examine if oral metformin is as effective as insulin in the prevention of fetal macrosomy in pregnancies complicated with gestational diabetes mellitus (GDM). DESIGN: Open-label prospective randomised controlled study. SETTING: Maternity outpatient clinics in a secondary and tertiary level hospital in Finland. SAMPLE: One hundred women with GDM who did not attain euglycaemia with diet. METHODS: Women were randomised to therapy with insulin (n = 50) or oral metformin (n = 50). MAIN OUTCOME MEASURES: Incidence of large-for-gestational-age (LGA) infants and neonatal morbidity. RESULTS: There were no statistically significant differences in the incidence of LGA (8.5 versus 10.0%, P = 0.97), mean birthweight, mean cord artery pH or neonatal morbidity between the insulin and metformin groups. Fifteen (31.9%) of the 47 women randomised to metformin needed supplemental insulin. They were more obese (with a body mass index of 36 versus 30 kg/m(2), P = 0.002), had higher fasting blood glucose levels in an oral glucose tolerance test (6.1 versus 5.0 mmol/l, P = 0.001) and needed medical treatment for GDM earlier (26 versus 31 gestational weeks, P = 0.002) than women who were normoglycemic with metformin. There was a tendency to a higher rate of caesarean sections in the metformin group than in the insulin group (RR 1.9; 95% CI 0.99-3.71). CONCLUSIONS: Metformin seems to be suitable for the prevention of fetal macrosomy, especially in lean or moderately overweight women developing GDM in late gestation. Women with considerable obesity, high fasting blood glucose and an early need for pharmacological treatment may be more suitable for insulin therapy.


Subject(s)
Diabetes, Gestational/drug therapy , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Metformin/therapeutic use , Adult , Body Mass Index , Female , Fetal Macrosomia/prevention & control , Humans , Obesity/complications , Outpatients , Pregnancy , Prospective Studies , Risk Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...